Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2022
Total Assets: $29.21B
Liabilities Breakdown FY2022
Total Liabilities: $6.55B
Asset Breakdown
Total Assets: $29.21B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.11B | 10.6% |
| Accounts Receivable | $5.33B | 18.2% |
| Inventory | $2.40B | 8.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $915.5M | 3.1% |
| Other Assets | $17.46B | 59.8% |
Liabilities Breakdown
Total Liabilities: $6.55B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $589.2M | 9.0% |
| Long-Term Debt | $1.98B | 30.2% |
| Other Liabilities | $3.98B | 60.8% |